Form 4: Edgewell Personal Care CFO Reports Stock Transactions

Edgewell Personal Care's Chief Financial Officer, Daniel Sullivan, reported the vesting of restricted stock equivalents and subsequent sale of shares to cover tax liabilities.

Summary

• Daniel Sullivan, the Chief Financial Officer of Edgewell Personal Care, filed a Form 4 detailing recent transactions involving the company's stock.
• On November 12, 2024, 2,772 restricted stock equivalents vested and were converted into common stock.
• Concurrently, 1,285 shares were sold at $35.35 per share to cover tax obligations related to the vesting.
• Following these transactions, Sullivan directly owns 90,498 shares of Edgewell Personal Care common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing of stock transactions by an executive, which is neither positive nor negative in itself.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The transactions reported are typical for executives receiving stock-based compensation, where shares are often sold to cover tax obligations upon vesting.
• Similar filings can be seen across the consumer goods sector, with companies like Procter & Gamble and Unilever having similar disclosures.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax-related sales.
• The filing provides transparency to stakeholders regarding insider trading activities.

Key Dates

Keywords

Form 4, Edgewell Personal Care, Daniel Sullivan, stock transaction, restricted stock, insider trading, tax liability